Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

1.07
Delayed Data
As of Jul 22
 -0.05 / -4.46%
Today’s Change
0.91
Today|||52-Week Range
7.60
-76.48%
Year-to-Date
Zafgen Halts Development of Beloranib, to Cut Jobs by ~34%
Jul 20 / Zacks.com - Paid Partner Content
TrovaGene Inks Partnership with USC Norris Cancer Center
Jul 13 / Zacks.com - Paid Partner Content
Celgene (CELG), Jounce Strike Immunotherapy Collaboration
Jul 20 / Zacks.com - Paid Partner Content
Bayer Expands Drug Discovery Collaboration with X-Chem
Jul 13 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Label Expansion Under U.S., EU Review
Jul 19 / Zacks.com - Paid Partner Content
Gilead's Pan-Genotypic HCV Drug Epclusa Gains EU Approval
Jul 11 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content
Amgen Humira Biosimilar Briefing Documents Look Good
Jul 11 / Zacks.com - Paid Partner Content
Celgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma
Jul 18 / Zacks.com - Paid Partner Content